ENSURE ALL INDIVIDUALS WITH
GENETIC RISKS FOR HEREDITARY
CANCERS RECEIVE IMPROVED
ACCESS TO EXPANDED COVERAGE
Up to 10% of all cancers are caused by cancer-related genetic mutations.
Reducing Hereditary Cancer Act (RHCA)
Why it's important: understanding your risk
Genetic testing can play a vital role in determining the risk of developing certain diseases and the need for screening or treatment. Expanded access to genetic testing can empower patients to learn their risk and take action before conditions progress.
What do you mean it's not covered?
Currently, Medicare only covers genetic testing for beneficiaries already diagnosed with cancer, regardless of family cancer history or a known genetic mutation in the family. This is problematic because knowledge of an inherited mutation can be essential for guiding decisions about cancer screening and prevention.
How does this act help?
The Reducing Hereditary Cancer Act (RHCA) aims to expand coverage for at-risk Medicare beneficiaries, particularly those with genetic risk for hereditary cancers, and to address a pressing need for increased access to genetic counseling, testing, cancer screening, and preventive care.
Let’s get this passed!
Help us champion the Reducing Hereditary Cancer Act. Contact your elected representatives and express your support for the act—urge them to prioritize this vital legislation to improve access for at-risk individuals.
